46 related articles for article (PubMed ID: 36585530)
1. Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus.
Lindblom J; Beretta L; Borghi MO; ; Alarcón-Riquelme ME; Parodis I
Front Immunol; 2023; 14():1257085. PubMed ID: 38098483
[TBL] [Abstract][Full Text] [Related]
2. The Contribution of Serum Sialic Acid Binding Immunoglobulin-Like Lectin 1(sSIGLEC-1) as an IFN I Signature Biomarker in the Progression of Atherosclerosis in Egyptian Systemic Lupus Erythematosus (SLE) Patients.
Nasser M; Wadie M; Farid A; El Amir A
Indian J Clin Biochem; 2024 Apr; 39(2):291-298. PubMed ID: 38577132
[TBL] [Abstract][Full Text] [Related]
3. Features of MRI honeycomb edema signals in cancer-associated dermatomyositis patients: a brief report.
Cheng X; Zhou M; Jiang J; Zhu S; Fang Q; Liu M
Clin Rheumatol; 2023 Mar; 42(3):801-806. PubMed ID: 36155870
[TBL] [Abstract][Full Text] [Related]
4. High serum immunoglobulin D levels in systemic lupus erythematosus: more to be found?
Liang P; Huang Q; Xu Y; Chen L; Li J; Xu A; Yang Q
Clin Rheumatol; 2023 Apr; 42(4):1069-1076. PubMed ID: 36585530
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of CD27
Zhang W; Wang YF; Hu FL; Lu FA; Wu T; Feng YL; Li K
Clin Rheumatol; 2022 May; 41(5):1551-1559. PubMed ID: 35032222
[TBL] [Abstract][Full Text] [Related]
6. Basophil count, a marker for disease activity in systemic lupus erythematosus.
Liang P; Tang Y; Fu S; Lv J; Liu B; Feng M; Li J; Lai D; Wan X; Xu A
Clin Rheumatol; 2015 May; 34(5):891-6. PubMed ID: 25403252
[TBL] [Abstract][Full Text] [Related]
7. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
[TBL] [Abstract][Full Text] [Related]
8. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
[TBL] [Abstract][Full Text] [Related]
9. Serum phosphatidylserine-specific phospholipase A
Sawada T; Kurano M; Shirai H; Iwasaki Y; Tahara K; Hayashi H; Igarashi K; Fujio K; Aoki J; Yatomi Y
Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressant exposure confounds gene expression analysis in systemic lupus erythematosus.
Northcott M; Gearing LJ; Bonin J; Koelmeyer R; Hoi A; Hertzog PJ; Morand EF
Front Immunol; 2022; 13():964263. PubMed ID: 36059457
[TBL] [Abstract][Full Text] [Related]
11. Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial.
Dörner T; van Vollenhoven RF; Doria A; Jia B; Ross Terres JA; Silk ME; de Bono S; Fischer P; Wallace DJ
Arthritis Res Ther; 2022 May; 24(1):112. PubMed ID: 35578304
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoints and the multiple faces of B cells in systemic lupus erythematosus.
Stefanski AL; Dörner T
Curr Opin Rheumatol; 2021 Nov; 33(6):592-597. PubMed ID: 34402453
[TBL] [Abstract][Full Text] [Related]
13. Predominant Role of Immunoglobulin G in the Pathogenesis of Splenomegaly in Murine Lupus.
Zhang Q; Xiang L; Zaman MH; Dong W; He G; Deng GM
Front Immunol; 2019; 10():3020. PubMed ID: 32082297
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
